EMA Unveils ERATO its new AI Tool improving Pharmacovigilance Signal Detection

Among the initiatives discussed by the European Medicines Agency (EMA) in its recently published annual report on 2024 activities was its new AI tool Enhanced Review of Abstracts with Transformer models (ERATO).

The purpose of ERATO is to reduce by an estimated 80% to 90% the roughly 200,000 abstracts the EMA Pharmacovigilance Office reviews every year. This could save more